Subtype
Diffuse Glioma
CI-CAN-00002519Explore in graph →
Non-malignant787 active trials5 approved drugs147 evidence items
Loading cancer entity…
Subtype
CI-CAN-00002519Explore in graph →
Clinical trials
2,804 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04737577 | Glioma Supra Marginal Incision Trial(G-SUMIT) | completed | N/A | 44 | Sunnybrook Health Sciences CentreOTHER | 2 | Aug 20, 2026 | clinicaltrials |
| NCT03739372 | Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma(PNOC008) | completed | N/A | 44 | University of California, San FranciscoOTHER | 1 | Aug 11, 2026 |
| clinicaltrials |
| NCT04730869 | Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma | completed | N/A | 18 | Waikato HospitalOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT02902757 | FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma | completed | N/A | 7 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT03477513 | Personalized Radiation Therapy for GBM | completed | N/A | 23 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT06368310 | FIH Clinical Investigation of Graphene Electrodes for Brain Mapping | completed | N/A | 10 | University of ManchesterOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT05644080 | 68Ga/177Lu-PSMA Theranostics in Recurrent Grade 3 and Grade 4 Glioma | completed | N/A | 10 | St. Olavs HospitalOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT03975959 | Memory Perception Assessment in Central/Non-central Nervous System Cancers(PROMESSE) | completed | N/A | 426 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT05186064 | Glioblastoma Targeted Treatment Option Maximization by WGS(GLOW) | completed | N/A | 164 | UMC UtrechtOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT03630289 | Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM | completed | N/A | 12 | Northwell HealthOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT02022800 | Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET)(IMOTEP) | completed | N/A | 85 | Centre Antoine LacassagneOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT02631655 | POSitron Emission Imaging Using 18F-FDOPA in Neurooncology(POSEIDON) | completed | N/A | 110 | Centre Antoine LacassagneOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT06294418 | FCI in Post-operative Low Grade Gliomas | completed | N/A | 9 | NHS GrampianOTHER_GOV | 1 | Apr 20, 2026 | clinicaltrials |
| NCT01872221 | Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study(STEMRI) | completed | N/A | 21 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT04988750 | Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients | completed | N/A | 7 | NaviFUS CorporationINDUSTRY | 1 | Apr 13, 2026 | clinicaltrials |
| NCT04446416 | Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients | completed | N/A | 6 | NaviFUS CorporationINDUSTRY | 1 | Apr 9, 2026 | clinicaltrials |
| NCT04471844 | Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM(EF-32) | completed | N/A | 981 | NovoCure Ltd.INDUSTRY | 11 | Mar 30, 2026 | clinicaltrials |
| NCT02286167 | Glioma Modified Atkins-based Diet in Patients With Glioblastoma(GLAD) | completed | N/A | 25 | Wake Forest University Health SciencesOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT03551249 | Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption | completed | N/A | 20 | InSightecINDUSTRY | 1 | Mar 20, 2026 | clinicaltrials |
| NCT05393258 | Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas | completed | N/A | 13 | Washington University School of MedicineOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT03257618 | Quality of Life and Neurocognitive Functioning(TEMOIN) | completed | N/A | 26 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT07416838 | Quality of Life and Cognitive Functioning in Patients With Glial Tumors | completed | N/A | 90 | Institute of Oncology LjubljanaOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT03450850 | Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma | completed | N/A | 1 | Daniela A. BotaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT03048240 | INtraoperative photoDYnamic Therapy of GliOblastoma(INDYGO) | completed | N/A | 10 | University Hospital, LilleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT05735171 | Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence(SupraGlio-AI) | completed | N/A | 20 | Hospital del Rio HortegaOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT04566185 | Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma(EVA DOPA) | completed | N/A | 14 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT02162732 | Molecular-Guided Therapy for Childhood Cancer | completed | N/A | 186 | Giselle ShollerOTHER | 2 | Nov 3, 2025 | clinicaltrials |
| NCT06327048 | Application of Cognitive Training Based on the Remind Strategy in Glioma Patients With Cognitive Impairment | completed | N/A | 69 | YuanYuan MaOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT05383872 | Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors | completed | N/A | 71 | InSightecINDUSTRY | 2 | Jul 28, 2025 | clinicaltrials |
| NCT04734444 | SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue | completed | N/A | 45 | SonoClear ASINDUSTRY | 3 | Jun 17, 2025 | clinicaltrials |
| NCT04610229 | Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.(GLIORAD) | completed | N/A | 12 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 1 | Jun 12, 2025 | clinicaltrials |
| NCT04766632 | Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent Gliomas(DORA) | completed | N/A | 16 | Central Hospital, Nancy, FranceOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT05759195 | Biomolecular Analysis for Predicting Response to Regorafenib(RegoRec) | completed | N/A | 53 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT05772767 | Modulation of Ciliogenesis in Glioma Stem Cells(RF2019-1236878) | completed | N/A | 100 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT05131815 | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors | completed | N/A | 8 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 26, 2025 | clinicaltrials |
| NCT05140902 | Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom | completed | N/A | 12 | University of Alabama at BirminghamOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT03154190 | Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer | completed | N/A | 128 | Stanford UniversityOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT05296122 | Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions | completed | N/A | 14 | Clinical Laserthermia Systems ABINDUSTRY | 1 | Jan 15, 2025 | clinicaltrials |
| NCT04539574 | An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors | completed | N/A | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 8, 2025 | clinicaltrials |
| NCT05015543 | Physical Training in Glioblastoma Patients During Cytotoxic Therapy(MMH) | completed | N/A | 54 | University Hospital MuensterOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT04109209 | Psychological Intervention For Brain Tumor Caregivers | completed | N/A | 120 | Massachusetts General HospitalOTHER | 1 | Dec 5, 2024 | clinicaltrials |
| NCT06713395 | PERMA-Based Intervention on Negative Emotions, Adherence, and Complications in Postoperative Glioma Patients(Glioma) | completed | N/A | 124 | Yang HuangOTHER_GOV | 1 | Dec 3, 2024 | clinicaltrials |
| NCT04726397 | UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial(UNITED) | completed | N/A | 108 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 29, 2024 | clinicaltrials |
| NCT03964909 | Resting-State Functional MRI in Glioma Patients Before and After Surgery | completed | N/A | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 15, 2024 | clinicaltrials |
| NCT03735498 | Psychological Intervention for Caregivers of Patients With Malignant Gliomas | completed | N/A | 13 | Massachusetts General HospitalOTHER | 1 | Nov 13, 2024 | clinicaltrials |
| NCT03922984 | Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma | completed | N/A | 43 | University of Texas Southwestern Medical CenterOTHER | 1 | Oct 22, 2024 | clinicaltrials |
| NCT03926507 | F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery | completed | N/A | 12 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 9, 2024 | clinicaltrials |
| NCT03278249 | Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma | completed | N/A | 12 | University of CincinnatiOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT01923922 | CT Perfusion in the Prognostication of Cerebral High Grade Glioma | completed | N/A | 48 | Nova Scotia Health AuthorityOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT06563024 | 18F-FET PET/CT in the Management of Glioma | completed | N/A | 36 | Buddhist Tzu Chi General HospitalOTHER | 1 | Aug 20, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Aug 20, 2026source: clinicaltrials